Atherosclerotic plaque formation;Formation de la plaque atherosclereuse

Revue du Praticien

Volumn 49, Issue 19, 1999, Pages 2081-2086

  Tedgui, Alain ^a   Mallat, Ziad ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ARTERY INTIMA; ATHEROSCLEROTIC PLAQUE; FIBROMUSCULAR DYSPLASIA; FOAM CELL; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MACROPHAGE; NONHUMAN; REVIEW; ARTERIOSCLEROSIS; ARTICLE; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ARTERIOSCLEROSIS; CYTOKINES; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES;

EID: 0033486104     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Stary HC, Blankenhorn DH, Chandler AB et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions - a report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation 1992;85:391-405.
2. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson G. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Atherosclerosis 1986;6:131-8.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
4. Napoli C, D'Armiento FP, Mancini FP et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100:2680-90.
5. Curmi PA, Juan L, Tedgui A. Effect of transmural pressure on low density lipoprotein and albumin transport and distribution across the intact arterial wall. Circ Res 1990;66:1692-702.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
7. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998;141:1-15.
8. Mallat Z, Nakamura T, Ohan J et al. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest 1999;103:421-7.
9. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998;18:842-51.
10. Shih PT, Brennan ML, Vora DK et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res 1999;84:345-51.
11. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-7.
12. Gu L, Okada Y, Clinton SK et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-81.
13. Boring L, Gosling I, Cleary M, Charo IF. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-7.
14. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990;10:680-7.
15. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992;140:301-16.
16. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 1995;92:8264-8.
17. Suzuki H, Kurihara Y, Takeya M et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997;386:292-6.
18. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1223-30.
19. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94: 2493-503.
20. Gupta S, Pablo AM, Jiang XC, Wang N, Tall AR, Schindler C. IFN-gamma potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 1997;99:2752-61.
21. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 1993; 685:713-39.
22. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa b (nf kappa b) activation in human monocytes - 11-10 and 11-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995;270: 9558-63.
23. Uyemura K, Demer LL, Castle SC et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996;97:2130-8.
24. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates timp-1 production in human mononuclear phagocytes. J Clin Invest 1995;96:2304-10.
25. Mallat Z, Heymes C, Ohan J, Faggin E, Lesèche G, Tedgui A. Expression of interleukin-10 in human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999;19: 611-6.
26. Mallat Z, Besnard S, Duriez M et al. Protective role of interleukin-10 in atherosclérosis. Cir Res 1999;85:e17-e24.